Literature DB >> 8227066

Enhanced activation of the human histone H2B promoter by an Oct-1 variant generated by alternative splicing.

G Das1, W Herr.   

Abstract

POU homeodomain proteins are important regulators of ubiquitous as well as tissue-specific transcription. These factors include the broadly expressed octamer motif-binding protein Oct-1 and the related cell-specifically expressed protein Oct-2. These two proteins differ in the types of octamer motif-containing promoters they preferentially activate; Oct-1 can activate RNA polymerase II transcription from a small nuclear RNA promoter better than Oct-2, which can better activate an mRNA-type promoter. We describe a variant Oct-1-encoding cDNA resulting from two separate alternate splices of the human oct-1 primary transcript; these alternate splices were present in all cell lines tested. This cDNA encodes an amino-terminally and carboxyl-terminally truncated form of Oct-1, called Oct-1B, which retains the DNA-binding POU domain and acquires a unique 12-amino acid carboxyl-terminal extension. In a transient expression assay, Oct-1B displayed an enhanced ability compared to the larger form of Oct-1 (called Oct-1A in this report) to activate the human histone H2B promoter, an mRNA-type promoter where a natural octamer motif is involved in cell cycle dependent transcription. Thus, the ability of Oct-1 related proteins to activate a natural regulatory target can be influenced by alternative splicing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227066

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  [Molecular-genetic mechanisms of developing the brain based on an embryonic Xenopus model].

Authors:  A G Zaraĭskiĭ
Journal:  Mol Biol (Mosk)       Date:  2004 Jan-Feb

2.  Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription.

Authors:  P C Shah; E Bertolino; H Singh
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

Review 3.  Multiple steps in the regulation of transcription-factor level and activity.

Authors:  C F Calkhoven; G Ab
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

Review 4.  POU domain transcription factors in embryonic development.

Authors:  G J Veenstra; P C van der Vliet; O H Destrée
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

5.  Functional characterization of the cis-regulatory elements of the rat ribophorin I gene.

Authors:  A K Rajasekaran; Z Zhou; K Prakash; G Das; G Kreibich
Journal:  Nucleic Acids Res       Date:  1995-02-11       Impact factor: 16.971

6.  The POU transcription factor Oct-1 represses virus-induced interferon A gene expression.

Authors:  Thibault Mesplède; Marie-Laure Island; Nicolas Christeff; Fahrettin Petek; Janine Doly; Sébastien Navarro
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

7.  Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets.

Authors:  N S Belaguli; W Zhou; T H Trinh; M W Majesky; R J Schwartz
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

8.  Stimulation of basal transcription from the mouse mammary tumor virus promoter by Oct proteins.

Authors:  M H Kim; D O Peterson
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  The POU homeodomain transcription factor Oct-1 is essential for activity of the gonadotropin-releasing hormone neuron-specific enhancer.

Authors:  M E Clark; P L Mellon
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

10.  Different N-terminal isoforms of Oct-1 control expression of distinct sets of genes and their high levels in Namalwa Burkitt's lymphoma cells affect a wide range of cellular processes.

Authors:  Elizaveta V Pankratova; Alexander G Stepchenko; Tatiana Portseva; Vladic A Mogila; Sofia G Georgieva
Journal:  Nucleic Acids Res       Date:  2016-07-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.